Overview

Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether quinacrine is effective in the treatment of Androgen-Independent Prostate Cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Cleveland BioLabs
Treatments:
Androgens
Quinacrine